Tag Archives: Sonya Marshall-Gradisnik

Rituximab impedes natural killer cell function in CFS/ME patients

Research abstract: Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation by Natalie Eaton, Hélène Cabanas, Cassandra Balinas, Anne Klein, Donald Staines and Sonya Marshall-Gradisnik in BMC Pharmacology and Toxicology 2018 19:12 [Published: … Continue reading

Posted in News | Tagged , , , , , , , , , , | Comments Off on Rituximab impedes natural killer cell function in CFS/ME patients

Protein kinase gene dysfunction in severe CFS/ME

Research abstract: Background: The etiology and pathomechanism of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) are unknown. However, natural killer (NK) cell dysfunction, in particular reduced NK cytotoxic activity, is a consistent finding in CFS/ME patients. Previous research has reported significant changes … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Protein kinase gene dysfunction in severe CFS/ME